Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma

Molecular and Cellular Endocrinology

Volumn 351, Issue 1, 2012, Pages 2-11

  Simon, Derek P ^a   Hammer, Gary D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

catenin; Adrenocortical carcinoma; Hedgehog signaling; IGF2; Sf1; Stem cell

Indexed keywords

BETA CATENIN; PROTEIN P53; SOMATOMEDIN; SONIC HEDGEHOG PROTEIN; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR GLI1; WNT PROTEIN;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX CELL; ADRENAL CORTEX STEM CELL; APC GENE; BETA CATENIN GENE; CANCER GROWTH; CARCINOGENESIS; CELL RENEWAL; DAX1 GENE; GAIN OF FUNCTION MUTATION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; IGF2 GENE; INHIBIN ALPHA; LOSS OF FUNCTION MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; POD1 GENE; PREF1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE; TUMOR SUPPRESSOR GENE;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PLURIPOTENT STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84857123759     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.12.006     Document Type: Review

References (117)

1. Almeida M.Q., Fragoso M.C., Lotfi C.F., Santos M.G., Nishi M.Y., Costa M.H., Lerario A.M., Maciel C.C., Mattos G.E., Jorge A.A., Mendonca B.B., Latronico A.C. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 93:3524-3531.
2. Almeida M.Q., Soares I.C., Ribeiro T.C., Fragoso M.C., Marins L.V., Wakamatsu A., Ressio R.A., Nishi M.Y., Jorge A.A., Lerario A.M., Alves V.A., Mendonca B.B., Latronico A.C. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J. Clin. Endocrinol. Metab. 2010, 95:1458-1462.
3. Arab K., Smith L.T., Gast A., Weichenhan D., Huang J., Claus R., Hielscher T., Espinosa A.V., Ringel M.D., Morrison C.D., Schadendorf D., Kumar R., Plass C. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis 2011.
4. Baquedano M.S., Berensztein E., Saraco N., Dorn G.V., de Davila M.T., Rivarola M.A., Belgorosky A. Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Pediatr. Res. 2005, 58:451-458.
5. Bernichtein S., Petretto E., Jamieson S., Goel A., Aitman T.J., Mangion J.M., Huhtaniemi I.T. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology 2008, 149:651-661.
6. Berthon A., Sahut-Barnola I., Lambert-Langlais S., de Joussineau C., Damon-Soubeyrand C., Louiset E., Taketo M.M., Tissier F., Bertherat J., Lefrancois-Martinez A.M., Martinez A., Val P. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 2010, 19:1561-1576.
7. Beuschlein F., Mutch C., Bavers D.L., Ulrich-Lai Y.M., Engeland W.C., Keegan C., Hammer G.D. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143:3122-3135.
8. Beuschlein F., Reincke M., Karl M., Travis W.D., Jaursch-Hancke C., Abdelhamid S., Chrousos G.P., Allolio B. Clonal composition of human adrenocortical neoplasms. Cancer Res. 1994, 54:4927-4932.
9. Bonnet S., Gaujoux S., Launay P., Baudry C., Chokri I., Ragazzon B., Libe R., Rene-Corail F., Audebourg A., Vacher-Lavenu M.C., Groussin L., Bertagna X., Dousset B., Bertherat J., Tissier F. Wnt/beta-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J. Clin. Endocrinol. Metab. 2011, 96:E419-E426.
10. Caspary T., Cleary M.A., Perlman E.J., Zhang P., Elledge S.J., Tilghman S.M. Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev. 1999, 13:3115-3124.
11. Ching S., Vilain E. Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009, 47:628-637.
12. Coulter C.L. Fetal adrenal development: insight gained from adrenal tumors. Trends Endocrinol. Metab. 2005, 16:235-242.
13. Crawford P.A., Dorn C., Sadovsky Y., Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell Biol. 1998, 18:2949-2956.
14. Cui S., Ross A., Stallings N., Parker K.L., Capel B., Quaggin S.E. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 2004, 131:4095-4105.
15. Dahl E., Wiesmann F., Woenckhaus M., Stoehr R., Wild P.J., Veeck J., Knuchel R., Klopocki E., Sauter G., Simon R., Wieland W.F., Walter B., Denzinger S., Hartmann A., Hammerschmied C.G. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007, 26:5680-5691.
16. DeBaun M.R., Niemitz E.L., McNeil D.E., Brandenburg S.A., Lee M.P., Feinberg A.P. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am. J. Hum. Genet. 2002, 70:604-611.
17. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L., Lalli E. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21:2968-2987.
18. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
19. El Wakil A., Lalli E. The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol. Cell Endocrinol. 2011, 332:32-37.
20. El-Khairi R., Martinez-Aguayo A., Ferraz-de-Souza B., Lin L., Achermann J.C. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocrinol. Dev. 2011, 20:38-46.
21. Else T., Hammer G.D. Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab. 2005, 16:458-468.
22. Else T., Trovato A., Kim A.C., Wu Y., Ferguson D.O., Kuick R.D., Lucas P.C., Hammer G.D. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell 2009, 15:465-476.
23. Faical S., Maciel R.M., Nose-Alberti V., Santos M.C., Kater C.E. Immunodetection of insulin-like growth factor I (IGF-l) in normal and pathological adrenocortical tissue. Endocrinol. Pathol. 1998, 9:63-70.
24. Fassnacht M., Libe R., Kroiss M., Allolio B. Adrenocortical carcinoma: a clinician's update. Nat. Rev. Endocrinol. 2011, 7:323-335.
25. Floridon C., Jensen C.H., Thorsen P., Nielsen O., Sunde L., Westergaard J.G., Thomsen S.G., Teisner B. Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 2000, 66:49-59.
26. Ford J.K., Young R.W. Cell proliferation and displacement in the adrenal cortex of young rats injected with tritiated thymidine. Anat. Rec. 1963, 146:125-137.
27. Gaujoux S., Grabar S., Fassnacht M., Ragazzon B., Launay P., Libe R., Chokri I., Audebourg A., Royer B., Sbiera S., Vacher-Lavenu M.C., Dousset B., Bertagna X., Allolio B., Bertherat J., Tissier F. Beta-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma. Clin. Cancer Res. 2011, 17:328-336.
28. Gaujoux S., Pinson S., Gimenez-Roqueplo A.P., Amar L., Ragazzon B., Launay P., Meatchi T., Libe R., Bertagna X., Audebourg A., Zucman-Rossi J., Tissier F., Bertherat J. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin. Cancer Res. 2010, 16:5133-5141.
29. Gaujoux S., Tissier F., Groussin L., Libe R., Ragazzon B., Launay P., Audebourg A., Dousset B., Bertagna X., Bertherat J. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 93:4135-4140.
30. Gicquel C., Bertagna X., Gaston V., Coste J., Louvel A., Baudin E., Bertherat J., Chapuis Y., Duclos J.M., Schlumberger M., Plouin P.F., Luton J.P., Le Bouc Y. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61:6762-6767.
31. Gicquel C., Bertagna X., Schneid H., Francillard-Leblond M., Luton J.P., Girard F., Le Bouc Y. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 1994, 78:1444-1453.
32. Gicquel C., Leblond-Francillard M., Bertagna X., Louvel A., Chapuis Y., Luton J.P., Girard F., Le Bouc Y. Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin. Endocrinol. (Oxf.) 1994, 40:465-477.
33. Giordano T.J. Adrenocortical tumors: an integrated clinical, pathologic, and molecular approach at the University of Michigan. Arch. Pathol. Lab. Med. 2010, 134:1440-1443.
34. Giordano T.J., Kuick R., Else T., Gauger P.G., Vinco M., Bauersfeld J., Sanders D., Thomas D.G., Doherty G., Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
35. Guasti L., Paul A., Laufer E., King P. Localization of Sonic hedgehog secreting and receiving cells in the developing and adult rat adrenal cortex. Mol. Cell Endocrinol. 2011, 336:117-122.
36. Gummow B.M., Scheys J.O., Cancelli V.R., Hammer G.D. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol. Endocrinol. 2006, 20:2711-2723.
37. Gummow B.M., Winnay J.N., Hammer G.D. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J. Biol. Chem. 2003, 278:26572-26579.
38. Halder S.K., Takemori H., Hatano O., Nonaka Y., Wada A., Okamoto M. Cloning of a membrane-spanning protein with epidermal growth factor-like repeat motifs from adrenal glomerulosa cells. Endocrinology 1998, 139:3316-3328.
39. Hall J.G., Pallister P.D., Clarren S.K., Beckwith J.B., Wiglesworth F.W., Fraser F.C., Cho S., Benke P.J., Reed S.D. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly - a new syndrome? Part I: clinical, causal, and pathogenetic considerations. Am. J. Med. Genet. 1980, 7:47-74.
40. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
41. Harari A., Inabnet W.B. Malignant pheochromocytoma: a review. Am. J. Surg. 2011, 201:700-708.
42. Harper J., Burns J.L., Foulstone E.J., Pignatelli M., Zaina S., Hassan A.B. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting. Cancer Res. 2006, 66:1940-1948.
43. Hatano O., Takakusu A., Nomura M., Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996, 1:663-671.
44. Huang C.C., Miyagawa S., Matsumaru D., Parker K.L., Yao H.H. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology 2010, 151:1119-1128.
45. Ilvesmaki V., Blum W.F., Voutilainen R. Insulin-like growth factor-II in human fetal adrenals: regulation by ACTH, protein kinase C and growth factors. J. Endocrinol. 1993, 137:533-542.
46. Ito M., Yu R., Jameson J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell Biol. 1997, 17:1476-1483.
47. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 1994, 4:1-7.
48. Jordan B.K., Mohammed M., Ching S.T., Delot E., Chen X.N., Dewing P., Swain A., Rao P.N., Elejalde B.R., Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am. J. Hum. Genet. 2001, 68:1102-1109.
49. Kamio T., Shigematsu K., Kawai K., Tsuchiyama H. Immunoreactivity and receptor expression of insulin like growth factor I and insulin in human adrenal tumors: an immunohistochemical study of 94 cases. Am. J. Pathol. 1991, 138:83-91.
50. Kang S., Graham J.M., Olney A.H., Biesecker L.G. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet. 1997, 15:266-268.
51. Keegan C.E., Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol. Metab. 2002, 13:200-208.
52. Kim A.C., Barlaskar F.M., Heaton J.H., Else T., Kelly V.R., Krill K.T., Scheys J.O., Simon D.P., Trovato A., Yang W.H., Hammer G.D. In search of adrenocortical stem and progenitor cells. Endocrinol. Rev. 2009, 30:241-263.
53. Kim A.C., Hammer G.D. Adrenocortical cells with stem/progenitor cell properties: recent advances. Mol. Cell. Endocrinol. 2007, 265-266:10-16.
54. Kim A.C., Reuter A.L., Zubair M., Else T., Serecky K., Bingham N.C., Lavery G.G., Parker K.L., Hammer G.D. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008, 135:2593-2602.
55. King P., Paul A., Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc. Natl. Acad. Sci. USA 2009, 106:21185-21190.
56. Korkaya H., Wicha M.S. Cancer stem cells: nature versus nurture. Nat. Cell Biol. 2010, 12:419-421.
57. Lako M., Strachan T., Bullen P., Wilson D.I., Robson S.C., Lindsay S. Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 1998, 219:101-110.
58. Latronico A.C., Pinto E.M., Domenice S., Fragoso M.C., Martin R.M., Zerbini M.C., Lucon A.M., Mendonca B.B. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 2001, 86:4970-4973.
59. Lin L., Gu W.X., Ozisik G., To W.S., Owen C.J., Jameson J.L., Achermann J.C. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J. Clin. Endocrinol. Metab. 2006, 91:3048-3054.
60. Lin Y., Liu A., Zhang S., Ruusunen T., Kreidberg J.A., Peltoketo H., Drummond I., Vainio S. Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev. Dyn. 2001, 222:26-39.
61. Looyenga B.D., Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol. 2006, 20:2848-2863.
62. Looyenga B.D., Wiater E., Vale W., Hammer G.D. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. Mol. Endocrinol. 2010, 24:608-620.
63. Lu J., Richardson J.A., Olson E.N. Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech. Dev. 1998, 73:23-32.
64. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
65. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
66. Marchesa P., Fazio V.W., Church J.M., McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Dis. Colon. Rectum. 1997, 40:1023-1028.
67. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocrinol. Rev. 1997, 18:378-403.
68. Mesiano S., Katz S.L., Lee J.Y., Jaffe R.B. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J. Clin. Endocrinol. Metab. 1997, 82:1390-1396.
69. Mesiano S., Mellon S.H., Jaffe R.B. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 1993, 76:968-976.
70. Mitani F., Mukai K., Miyamoto H., Suematsu M., Ishimura Y. Development of functional zonation in the rat adrenal cortex. Endocrinology 1999, 140:3342-3353.
71. Mizusaki H., Kawabe K., Mukai T., Ariyoshi E., Kasahara M., Yoshioka H., Swain A., Morohashi K. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Mol. Endocrinol. 2003, 17:507-519.
72. Mukai T., Kusaka M., Kawabe K., Goto K., Nawata H., Fujieda K., Morohashi K. Sexually dimorphic expression of Dax-1 in the adrenal cortex. Genes Cells 2002, 7:717-729.
73. Ng J.M., Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat. Rev. Cancer 2011, 11:493-501.
74. Ohgaki H., Kleihues P., Heitz P.U. P53 mutations in sporadic adrenocortical tumors. Int. J. Cancer 1993, 54:408-410.
75. Okamoto M., Takemori H., Halder S.K., Hatano O. Zona glomerulosa-specific factor: cloning and function. Steroids 1997, 62:73-76.
76. Perrone R.D., Bengele H.H., Alexander E.A. Sodium retention after adrenal enucleation. Am. J. Physiol. 1986, 250:E1-E12.
77. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R., Lalli E. SF-1 overexpression in childhood adrenocortical tumours. Eur. J. Cancer 2006, 42:1040-1043.
78. Polakis P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17:45-51.
79. Quaggin S.E., Vanden Heuvel G.B., Igarashi P. Pod-1, a mesoderm-specific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech. Dev. 1998, 71:37-48.
80. Ragazzon B., Assie G., Bertherat J. Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments. Endocrinol. Relat. Cancer 2011, 18:R15-R27.
81. Ragazzon B., Libe R., Gaujoux S., Assie G., Fratticci A., Launay P., Clauser E., Bertagna X., Tissier F., de Reynies A., Bertherat J. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Res. 2010, 70:8276-8281.
82. Reincke M., Karl M., Travis W.H., Mastorakos G., Allolio B., Linehan H.M., Chrousos G.P. P53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J. Clin. Endocrinol. Metab. 1994, 78:790-794.
83. Ribeiro R.C., Sandrini F., Figueiredo B., Zambetti G.P., Michalkiewicz E., Lafferty A.R., DeLacerda L., Rabin M., Cadwell C., Sampaio G., Cat I., Stratakis C.A., Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. USA 2001, 98:9330-9335.
84. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
85. Robb L., Mifsud L., Hartley L., Biben C., Copeland N.G., Gilbert D.J., Jenkins N.A., Harvey R.P. Epicardin: a novel basic helix-loop-helix transcription factor gene expressed in epicardium, branchial arch myoblasts, and mesenchyme of developing lung, gut, kidney, and gonads. Dev. Dyn. 1998, 213:105-113.
86. Rosati R., Cerrato F., Doghman M., Pianovski M.A., Parise G.A., Custodio G., Zambetti G.P., Ribeiro R.C., Riccio A., Figueiredo B.C., Lalli E. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Cancer Genet. Cytogenet. 2008, 186:19-24.
87. Ryan P.D., Goss P.E. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 2008, 13:16-24.
88. Sbiera S., Schmull S., Assie G., Voelker H.U., Kraus L., Beyer M., Ragazzon B., Beuschlein F., Willenberg H.S., Hahner S., Saeger W., Bertherat J., Allolio B., Fassnacht M. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab. 2010, 95:E161-E171.
89. Schaberg A. Regeneration of the adrenal cortex in vitro. Anat. Rec. 1955, 122:205-221.
90. Scheys J.O., Heaton J.H., Hammer G.D. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology 2011.
91. Schulte D.M., Shapiro I., Reincke M., Beuschlein F. Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. Gene Expr. Patterns 2007, 7:72-81.
92. Shigematsu K., Niwa M., Kurihara M., Yamashita K., Kawai K., Tsuchiyama H. Receptor autoradiographic localization of insulin-like growth factor-I (IGF-I) binding sites in human fetal and adult adrenal glands. Life Sci. 1989, 45:383-389.
93. Smas C.M., Sul H.S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993, 73:725-734.
94. Smith L.T., Lin M., Brena R.M., Lang J.C., Schuller D.E., Otterson G.A., Morrison C.D., Smiraglia D.J., Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl. Acad. Sci. USA 2006, 103:982-987.
95. Smith T.G., Clark S.K., Katz D.E., Reznek R.H., Phillips R.K. Adrenal masses are associated with familial adenomatous polyposis. Dis. Colon Rectum. 2000, 43:1739-1742.
96. Sotelo-Avila C., Gonzalez-Crussi F., Fowler J.W. Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential. J. Pediatr. 1980, 96:47-50.
97. Stratakis C.A., Boikos S.A. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:748-757.
98. Susaki E., Nakayama K., Yamasaki L., Nakayama K.I. Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model. Proc. Natl. Acad. Sci. USA 2009, 106:5192-5197.
99. Suwa T., Chen M., Hawks C.L., Hornsby P.J. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. J. Endocrinol. 2003, 178:149-158.
100. Tamura M., Kanno Y., Chuma S., Saito T., Nakatsuji N. Pod-1/Capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech. Dev. 2001, 102:135-144.
101. Tanimizu N., Tsujimura T., Takahide K., Kodama T., Nakamura K., Miyajima A. Expression of Dlk/Pref-1 defines a subpopulation in the oval cell compartment of rat liver. Gene Expr. Patterns 2004, 5:209-218.
102. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., Hagnere A.M., Rene-Corail F., Jullian E., Gicquel C., Bertagna X., Vacher-Lavenu M.C., Perret C., Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005, 65:7622-7627.
103. Turanyi E., Dezso K., Paku S., Nagy P. DLK is a novel immunohistochemical marker for adrenal gland tumors. Virchows Arch. 2009, 455:295-299.
104. Val P., Martinez-Barbera J.P., Swain A. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 2007, 134:2349-2358.
105. Varley J.M., McGown G., Thorncroft M., James L.A., Margison G.P., Forster G., Evans D.G., Harris M., Kelsey A.M., Birch J.M. Are there low-penetrance TP53 Alleles? Evidence from childhood adrenocortical tumors. Am. J. Hum. Genet. 1999, 65:995-1006.
106. Varrault A., Gueydan C., Delalbre A., Bellmann A., Houssami S., Aknin C., Severac D., Chotard L., Kahli M., Le Digarcher A., Pavlidis P., Journot L. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev. Cell 2006, 11:711-722.
107. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
108. Weber M.M., Fottner C., Schmidt P., Brodowski K.M., Gittner K., Lahm H., Engelhardt D., Wolf E. Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology 1999, 140:1537-1543.
109. Weksberg R., Shuman C., Beckwith J.B. Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 2010, 18:8-14.
110. West A.N., Neale G.A., Pounds S., Figueredo B.C., Rodriguez Galindo C., Pianovski M.A., Oliveira Filho A.G., Malkin D., Lalli E., Ribeiro R., Zambetti G.P. Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 2007, 67:600-608.
111. Wolf E., Kramer R., Blum W.F., Foll J., Brem G. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 1994, 135:1877-1886.
112. Wood M.A., Hammer G.D. Adrenocortical stem and progenitor cells: unifying model of two proposed origins. Mol. Cell Endocrinol. 2011, 336:206-212.
113. Yanai H., Nakamura K., Hijioka S., Kamei A., Ikari T., Ishikawa Y., Shinozaki E., Mizunuma N., Hatake K., Miyajima A. Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J. Biochem. 2010, 148:85-92.
114. Yu R.N., Ito M., Jameson J.L. The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Mol. Endocrinol. 1998, 12:1010-1022.
115. Yu R.N., Ito M., Saunders T.L., Camper S.A., Jameson J.L. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 1998, 20:353-357.
116. Zubair M., Ishihara S., Oka S., Okumura K., Morohashi K. Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol. Cell Biol. 2006, 26:4111-4121.
117. Zubair M., Parker K.L., Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol. Cell Biol. 2008, 28:7030-7040.